FDA Import Refusal 310-5860456-7/1/1 — Celgene Cellular Therapeutics
The FDA refused shipment 310-5860456-7/1/1 from Celgene Cellular Therapeutics (United States) on Nov 19, 2002. The refused product falls under Drugs and Biologics — THALIDOMIDE (SEDATIVE). Cited charge: 179 This firm has 3 other import refusals on record.
Refusal details
- Date
- Nov 19, 2002
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 65VCF40 THALIDOMIDE (SEDATIVE)
- Charges
- 179